Table 1.

Summary of randomized trials and prospective studies reporting the incidence of unknown cancer detected with screening and during follow up in patients presenting with VTE

Summary of randomized trials and prospective studies reporting the incidence of unknown cancer detected with screening and during follow up in patients presenting with VTE

Abdo, abdomen; AFP, alphafetoprotein; BE, barium enema; BM, bone marrow; CA, carbohydrate antigen; CEA, carcinoembryonic antigen; CBC, complete blood count; CI, confidence interval; creat, creatinine; CRP, C-reactive protein; CXR, chest radiography; DVT, deep vein thrombosis; ESR, erythrocyte sedimentation rate; f/u, follow up; Hx, history; LDH, lactic dehydrogenase; LFTs, liver function tests; LN, lymph node; mos, months; neg, negative; No., number; NSE, neuron-specific enolase; OR, odds ratio; PE, pulmonary embolus; NPV, negative predictive value; PPV, positive predictive value; PSA, prostate specific antigen; pts, patients; SCC, squamous-cell antigen; SPEP, serum protein electrophoresis; UA, urinanalysis; UGI, upper gastrointestinal; US, ultrasound; vs, versus; VTE, venous thromboembolism; w/u, work up; yrs, years

Close Modal

or Create an Account

Close Modal
Close Modal